You can’t buy weed with a credit card at a licensed dispensary because marijuana is still a Schedule I controlled substance under federal law, and every credit card swipe travels through federally regulated banks and card networks that refuse to process it. Visa, Mastercard, American Express, and Discover all prohibit cannabis sales on their networks, even in states where recreational and medical use are fully legal. That leaves you paying with cash, a PIN debit workaround, or a bank-to-bank transfer app — and paying extra for the inconvenience.
The Federal Law Behind the Block
Marijuana sits on Schedule I of the Controlled Substances Act alongside heroin and LSD.1Office of the Law Revision Counsel. 21 USC 812 – Schedules of Controlled Substances Every state legalization law in the country conflicts directly with that classification.
A card purchase isn’t a private exchange between you and the shop. It routes through an issuing bank, an acquiring bank, and a card network, all federally chartered or regulated. A bank that knowingly processes cannabis revenue risks money laundering charges under federal law, which treats proceeds from controlled substance sales as “specified unlawful activity.” Penalties can reach $500,000 in fines or twenty years in prison.2Office of the Law Revision Counsel. 18 USC 1956 – Laundering of Monetary Instruments No processor is going to accept that exposure so you can earn points on an eighth.
Why Banks Steer Clear of Cannabis
The card block is the visible piece of a bigger problem. Most banks won’t open a basic checking account for a dispensary, let alone process card transactions for one. The few that do charge premium fees to cover the compliance load.
In 2014, the Financial Crimes Enforcement Network issued guidance explaining how banks could serve state-legal cannabis businesses without automatically drawing federal prosecution. The condition: banks must file suspicious activity reports on every cannabis client, every quarter, for the life of the relationship.3FinCEN. BSA Expectations Regarding Marijuana-Related Businesses Most institutions weigh the paperwork, the legal exposure, and the reputational risk, and pass. That’s why dispensaries also struggle to get business loans, payroll accounts, and lines of credit.
How You Actually Pay at a Dispensary
Since the card networks won’t touch cannabis, dispensaries lean on a handful of alternatives. None are as smooth as a credit card, and most add cost at checkout.
- Cash is still the most common option. Most shops keep an ATM on site, though you’ll usually pay a surcharge of about $3 to $5 per withdrawal. Pulling cash from your own bank’s ATM before you go avoids the fee.
- Point-of-banking terminals are what shops usually mean when they advertise “debit accepted.” You insert a debit card and enter your PIN, but the transaction runs as a bank withdrawal rather than a purchase. Your total gets rounded up to the nearest $5, and you get the difference back in cash or store credit. A convenience fee is added on top.
- ACH transfer apps like Aeropay let you scan a QR code that pulls funds directly from your checking account through the Automated Clearing House network, skipping the card networks entirely. It feels closer to a normal digital payment, but you’re handing your bank account details to a cannabis-specific processor.
For context on the markup: ordinary card processing costs merchants 1 to 3 percent per transaction. Cannabis-specific alternatives typically charge dispensaries 3 to 8 percent, and many pass part of that along as a $2 to $5 convenience fee. Between ATM surcharges and rounding, the cash model quietly adds a few dollars to every visit.
The Cashless ATM Crackdown
For years, the dominant workaround was the “cashless ATM,” a point-of-sale terminal that dressed cannabis purchases up as ATM withdrawals. No cash actually moved. The dispensary got paid, the customer’s statement showed an ATM transaction, and the network’s cannabis prohibition was sidestepped through miscoding.
Visa closed in on the practice. In a compliance memo, the company said cashless ATMs “mimic standalone ATMs” but are really “used for purchase transactions, which are miscoded as ATM cash disbursements.” Visa flagged this as a violation of network rules, with non-compliance penalties, fines that can reach $2,500 per day retroactively, and permanent account termination. In 2025, Visa took public action against a multi-state operator, signaling that enforcement is active.
The exposure isn’t only contractual. Legal analysts have argued that miscoding cannabis sales could itself constitute a federal offense, since it involves deliberately misrepresenting the nature of transactions tied to a controlled substance. Dispensaries that built their card acceptance around cashless ATMs are now scrambling.
Privacy Risks in the Workarounds
At a normal retailer, your card runs through processors with decades of security infrastructure behind them. Cannabis payment vendors work in a gray zone the usual financial partners avoid, and the companies filling the gap don’t always have the same resources.
That risk hit the surface in late 2024, when STIIIZY, a major dispensary chain, disclosed that a point-of-sale vendor had been compromised by an organized cybercrime group. The exposed data included customer names, addresses, dates of birth, driver’s license numbers, passport numbers, government ID photos and signatures, medical cannabis card details, and full transaction histories. Leaked cannabis purchase records carry consequences a typical retail breach doesn’t. In states where legalization is recent or limited, that history can create professional, legal, or personal problems separate from identity theft.
Cannabis retailers rely heavily on third-party vendors for compliance tracking, inventory, and payments. Each vendor is a potential failure point, and the vendors willing to work in cannabis tend to be smaller and newer than the incumbents serving mainstream retail.
Would Rescheduling to Schedule III Change This?
No. As of 2026, the DEA has not issued a final rule reclassifying cannabis, despite a proposed rule in May 2024 and a December 2025 presidential executive order directing quick completion. The rulemaking is stalled: no administrative law judge has been assigned to the required hearing, and an unresolved procedural appeal is blocking any fast track.
Even if rescheduling happened tomorrow, it wouldn’t open card processing. Schedule III still means federally controlled. Drugs in that category, like ketamine and certain anabolic steroids, are legal only through FDA-approved channels with a valid prescription. A state-licensed dispensary selling recreational cannabis is not an FDA-compliant pharmacy. The card networks have said their prohibitions cover controlled substance sales outside approved pharmaceutical frameworks, and that they would need full federal legalization or an entirely new regulatory structure before revising the rule.
Rescheduling would help cannabis businesses on tax treatment and some banking relationships. Your credit card would still be declined at the counter.
Where Federal Banking Reform Stands
The realistic path to card acceptance runs through Congress, not the DEA. The SAFER Banking Act would create a legal safe harbor for banks and payment processors serving state-legal cannabis businesses.4Congress.gov. S.2860 – 118th Congress (2023-2024) – SAFER Banking Act It cleared the Senate Banking Committee with bipartisan support in September 2023, never received a floor vote, and died with the 118th Congress.
Versions of this bill have been introduced repeatedly since 2019. It has passed the House multiple times and stalled in the Senate every time. As of 2026, it remains a long-stalled reform with no clear timeline. Until Congress passes banking protections or cannabis is removed from the Controlled Substances Act entirely, the major networks have no legal incentive to change course. Bring cash or a debit card.